|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 38/16 | (2006.01) |
| A61K 48/00 | (2006.01) | ||
| C07K 14/00 | (2006.01) | ||
| C12N 15/86 | (2006.01) | ||
| A61P 27/16 | (2006.01) |
| (11) | Number of the document | 3911354 |
| (13) | Kind of document | T |
| (96) | European patent application number | 20701951.4 |
| Date of filing the European patent application | 2020-01-20 | |
| (97) | Date of publication of the European application | 2021-11-24 |
| (45) | Date of publication and mention of the grant of the patent | 2023-07-19 |
| (46) | Date of publication of the claims translation | 2023-11-27 |
| (86) | Number | PCT/EP2020/051283 |
| Date | 2020-01-20 |
| (87) | Number | WO 2020/148458 |
| Date | 2020-07-23 |
| (30) | Number | Date | Country code |
| 19305071 | 2019-01-18 | EP |
| (72) |
SAFIEDDINE, Saaid , FR
PETIT, Christine , FR
|
| (73) |
Institut Pasteur ,
25-28, rue du Docteur Roux, 75015 Paris,
FR
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) , 3, rue Michel-Ange, 75016 Paris, FR INSERM (Institut National de la Santé et de la Recherche Médicale) , 101, rue de Tolbiac, 75013 Paris, FR |
| (74) |
Aurelija ŠIDLAUSKIENĖ,
Dr. V. Šidlauskas ir partneriai, UAB, K. Būgos g. 29, LT-44326 Kaunas,
LT
|
| (54) | AAV mediacijos genų terapija, atstatanti otoferlino geną |
| AAV-MEDIATED GENE THERAPY RESTORING THE OTOFERLIN GENE |
| Payment date | Validity (years) | Amount | |
| 2025-12-29 | 7 | 162.00 EUR |
| 2027-01-20 |